๐ฐ Suraksha Program News
Suraksha Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Suraksha Program. Real-time updates on events, politics, business and more.
December 27, 2022
INCOVACC is now available on CoWin, and priced at Rs 800 for private markets and priced at Rs 325 for supplies to government of India and state governments.
December 27, 2022
INCOVACC is to be priced at INR 325 per dose for large volume procurement by State Governments and Govt of India, and INR 800 for Private Markets.
December 23, 2022
As of now, the situation is not alarming, so there is no need to panic, said a government press release.
December 23, 2022
The central government has approved the use of Bharat Biotech nasal Covid vaccine iNCOVACC to be included in the country vaccination programme as a booster
December 2, 2022
Excelsior Correspondent NEW DELHI, Dec 1 : World’s first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above. This was informed here today by Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, D...
December 2, 2022
The intra-nasal vaccine for COVID received approval under restricted Use in emergency situations for ages 18 and above for primary twoย dose schedule, homologous booster doses, Union minister Dr Jitendra Singh said.
December 2, 2022
Central Drugs Standard Control Organisation (CDSCO) has granted approval for Bharat Biotechโs BBV154 vaccine to treat Covid-19.
December 2, 2022
Vaccine receives approval under restricted use in emergency situations for 18 and above
December 1, 2022
Worlds first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above.
December 1, 2022
NEW DELHI, December 1 : Worldโs first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above. This was informed here today by Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh while ...